NM  Vol.2 No.4 , December 2011
Bright Light Treatment of Depression for 28 Adolescents
ABSTRACT
Background: Bright light therapy, an effective therapeutic option for depressive adults, could provide safe, economic, and effective rapid recovery also in adolescents. Method: This was a randomized cross-over trial, i.e. that 14 patients received first dim white light (50 lux) one hour a day for one week and then Bright light therapy (2500 Lux) for one week. 14 patients received first Bright light therapy and then dim white light. For assessment of depressive symptoms, Beck depression inventory scales were administered 1 week before and one day before dim white light treatment, on the day between dim white light and bright white light treatment, on the day after bright white light treatment and one week after bright white light treatment. Saliva melatonin and cortisol samples were collected at 08:00 a.m. and 08:00 p.m., 1 week before and one day before dim white light treatment, on the day between dim white light and bright white light treatment, on the day after bright white light treatment and one week after bright white light treatment and assayed for melatonin and cortisol to observe any change in circadian timing. Results: 28 volunteers, between 14 and 17 years old, completed the study. Beck depression inventory scores improved significantly. The assays of morning saliva melatonin showed significant differences between Bright white light and dim white light (p = 0.005), those of evening saliva melatonin and saliva cortisol did not show significant differences. No significant adverse reactions were observed. Conclusion: Antidepressant response to bright light treatment in this age group was statistically superior to dim white light

Cite this paper
nullH. Niederhofer and K. Klitzing, "Bright Light Treatment of Depression for 28 Adolescents," Neuroscience and Medicine, Vol. 2 No. 4, 2011, pp. 341-346. doi: 10.4236/nm.2011.24044.
References
[1]   Depression Guideline Panel, “Depression in Primary Care: Treatment of Major Depression,” Vol. 2, Agency for Health Care Policy and Research, Washington DC, HHS, AHCPR Publication No. 93-0551, U.S. Government Printing Office, 1993.

[2]   N. E. Rosenthal, “Light Therapy,” In: G. O. Gabbard, Ed., Treatment of Psychiatric Disorders, Vol. 1, American Psychiatric Press, Washington DC, 1995, pp. 1263-1273.

[3]   A. Tuunainen, D. F. Kripke and T. Endo, “Light Therapy for Non-Seasonal Depression (Cochrane Review),” The Cochrane Library, 2004.

[4]   R. Lieverse, E. J. Van someren, M. M. Nielen, B. M. uitdehaag, J. H. Smith and W. J. Hoogendijk, “Bright Light Treatment in Elderly Patients with Nonseasonal Major Depressive Disorder: A Randomized Placebo-Controlled Trial,” Archives of General Psychiatry, Vol. 68, No. 1, 2011, pp. 61-70. doi:10.1001/archgenpsychiatry.2010.183

[5]   F. Benedetti, S. Dallaspezia, M. C. Fulgosi, B. Barbini, C. Colombo and E. Smeraldi, “Phase Advance is an Arithmetic Coorelate of Antidepressant Response to Sleep Deprivation and Light Therapy in Bipolar Depression,” Chronobiology International, Vol. 24, No. 5, 2007, pp. 921-937. doi:10.1080/07420520701649455

[6]   A. J. Lewy, R. L. Sack, C. M. Singer, D. M. White and T. M. Hoban, “Winter Depression and the Phase-Shift Hypothesis for Bright Light’S Therapeutic Effects: History, Theory, and Experimental Evidence,” Journal of Biological Rhythms, Vol. 3, No. 2, 1988, pp. 121-134. doi:10.1177/074873048800300203

[7]   R. L. Sack, A. J. Lewy, D. M. White, C. M. Singer, M. J. Fireman and R. Vandiver, “Morning vs Evening Light Treatment for Winter Depression,” Archives of General Psychiatry, Vol. 47, No. 4, 1990, pp. 343-351.

[8]   D. H. Avery, A. Khan, S. R. Dager, S. A. Cohen, G. B. Cox and D. L. Dunner, “Morning or Evening Bright Light Treatment of Winter Depression? The Significance of Hypersomnia,” Biological Psychiatry, Vol. 29, No. 2, 1991, pp. 117-126. doi:10.1016/0006-3223(91)90040-S

[9]   J. S. Terman, M. Terman, E. S. Lo and T. B. Cooper, “Circadian Time of Morning Light Administration and Therapeutic Response in Winter Depression,” Archives of General Psychiatry, Vol. 58, No. 1, 2001, pp. 69-75. doi:10.1001/archpsyc.58.1.69

[10]   M. Terman, J. S. Terman, F. M. Quitkin, P. J. McGrath, J. W. Stewart and B. Rafferty, “Light Therapy for Seasonal Affective Disorder: A Review of Efficacy,” Neuropsy- chopharmacology, Vol. 2, 1989, pp. 1-22. doi:10.1016/0893-133X(89)90002-X

[11]   M. Terman and J. S. Terman, “Randomized, Controlled Trial of Bright Light, Dawn Simulation and Negative Air Ionization for Winter Depression [Abstract],” Society for Light Treatment and Biological Rhythms, Vol. 14, 2002, p. 25.

[12]   M. Terman, “Problems and prospects for use of bright light as a therapeutic intervention,” In: L. Wetterberg, Ed. Light and Biological Rhythms in Man. 1. Pergamon Press, Stockholm, 1993, pp. 421-436.

[13]   A. Tuunainen, D. F. Kripke, J. A. Elliott, J. D. Assmus, K. M. Rex, M. R. Klauber and R. D. Langer, “Depression and Endogenous Melatonin in Postmenopausal Women,” Journal of Affective Disorders, Vol. 69, No. 1, 2002; 149-158. doi:10.1016/S0165-0327(01)00303-2

[14]   T. A. Wehr, W. C. Duncan, L. Sher, D. Aeschbach, P. J. Schwartz, E. H. Turner, T. T. Postolache and N. E. Rosenthal, “A Circadian Signal of Change of Season in Patients with Seasonal Affective Disorder,” Archives of General Psychiatry, Vol. 58, No. 12, 2001, pp. 1108- 1114. doi:10.1001/archpsyc.58.12.1108

[15]   L. K. Sekula, J. F. Lucke, K. Heist, K. Czambel and R. T. Rubin, “Neuroendocrine Aspects of Primary Endogenous Depression XV: Mathematical Modeling of Nocturnal Melatonin Secretion in Major Depressives and Normal Controls,” Psychiatry Research, Vol. 69, No. 2-3, 1997, pp. 143-153. doi:10.1016/S0165-1781(96)02937-X

[16]   A. Neumeister, R. Goessler, M. Lucht, T. Kapitany, C. Bamas and S. Kasper, “Bright Light Therapy Stabilizes the Antidepressant Effect of Partial Sleep Deprivation,” Biological Psychiatry, Vol. 39, No. 1, 1996, pp. 16-21. doi:10.1016/0006-3223(95)00086-0

[17]   R. T. Loving, D. F. Kripke, J. A. Eliott, N. C. Knicker-bocker and M. A. Grandner, “Bright Light Treatment of Depression for Older Adults,” BMC Psychiatry, Vol. 9, 2005, p. 41. doi:10.1186/1471-244X-5-41

[18]   B. Bloching, C. Dechene and K. L. Taschner, “Outlasting Antidepressant Effect of Late Partial Sleep Deprivation by Bright Light Therapy,” Journal of Sleep Research, Vol. 9, 2000, p. 21.

[19]   H. Niederhofer and K. Klitzing, “Therapy Augmentation by Bright Light Treatment for Non-Seasonal Depression of Adolescents,” Clinical Neuropsychiatry, in press

[20]   A. T. Beck, C. H. Ward, M. Mendelson, J. Mock and J. Erbaugh, “An Inventory for Measuring Depression,” Archives of General Psychiatry, Vol. 4, 1961, pp. 561-571.

[21]   C. Moynihan, “Instruction Manual for Systematic Assessment for Treatment Emergent Events (SAFTEE),” ADAMHA, Rockville, MD, 1983.

[22]   A. Wirz-Justice, F. benedetti, M. Berger, R. W. Lam, K. Martiny, M. Terman and J. C. Wu, “Chronotherapeutics (Light and Wake Therapy) in Affective Disorders,” Psychological Medicine, Vol. 35, No. 7, 2005, pp. 939-944. doi:10.1017/S003329170500437X

[23]   A. Khan, H. A. Warner and W. A. Brown, “Symptom Reduction and Suicide Risk in Patients Treated with Placebo in Antidepressant Clinical Trials,” Archives of General Psychiatry, Vol. 57, No. 4, 2000, pp. 311-328. doi:10.1001/archpsyc.57.4.311

[24]   C. I. Eastman, “What the Placebo Literature Can Tell Us about Light Therapy for SAD,” Psychopharmacology Bulletin, Vol. 26, 1990, pp. 495-504.

[25]   G. C. Brainard, M. D. Rollag and J. P. Hanifin, “Photic Regulation of Melatonin in Humans: Ocular and Neural Signal Transduction,” Journal of Biological Rhythms, Vol. 12, No. 6, 1997, pp. 537-546. doi:10.1177/074873049701200608

 
 
Top